Top 25 Companies in Global C-Reactive Protein Testing Market: Strategic Overview and Future Trends (2026–2035)
RELEASE DATE: Apr 2026 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a research report published by Spherical Insights & Consulting, The Global C-Reactive Protein Testing Market Size is projected to grow from USD 5.23 Billion in 2025 to USD 7.45 Billion by 2035, at a CAGR of 3.6% during the forecast period 2026–2035. The C-Reactive Protein (CRP) testing market is driven by rising prevalence of inflammatory and cardiovascular diseases, increasing demand for early diagnosis, growing healthcare awareness, expanding diagnostic infrastructure, and technological advancements in rapid testing solutions.
Introduction
A C-Reactive Protein (CRP) Testing Market is a worldwide industry based on the use of diagnostic assays to measure C-Reactive Protein (CRP), which is an acute phase protein produced in the liver in response to inflammation. The CRP Test is used extensively to help diagnose people's infections and help monitor those with chronic illnesses. The main raw materials needed to manufacture CRP Testing products are: Antibodies, Reagents, Assay Kits, Calibrators, Biological Samples (Serum or Plasma). Market growth is primarily driven by increasing numbers of patients with cardiovascular diseases, autoimmune disorders and infections, along with increasing demand for early diagnosis and preventative health care. The various types of facilities in which CRP Testing will occur include hospitals, diagnostic laboratories, clinics, and point-of-care environments, for the purposes of monitoring inflammation and determining the risk of cardiovascular disease. In response to increased incidence of cardiovascular disease, government agencies are encouraging the use of CRP Testing through promotion of screening programs and promotion of strategies to decrease antimicrobial resistance. The most recent advancements in CRP Testing Technology include; Artificial Intelligence (AI) now being used in diagnostic systems; development of sophisticated immunoassays; and FDA or other regulatory agencies providing even greater capability for laboratories to conduct CRP Testing via; regulatory approvals or strategic collaborations. Current technological advances in CRP Testing Technology include; increased sensitivity of CRP testing assays (high-sensitivity CRP testing), use of electrochemical biosensors to conduct CRP Testing; and continued development of wearable Microneedle Detection Systems to conduct rapid, accurate, non-invasive testing.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
In March 2026, global healthcare companies expanded investments in advanced diagnostic technologies, accelerating adoption of high-sensitivity CRP assays for early disease detection and improving clinical decision-making outcomes.
In February 2025, industry reports highlighted steady growth in the CRP testing market due to increasing demand for precision diagnostics and rising prevalence of inflammatory and cardiovascular diseases globally.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the C-Reactive Protein Testing Market.
Market Segmentation
Global C-Reactive Protein (CRP) Testing Market Size, Share, and COVID-19 Impact Analysis, By Type (High-Sensitivity CRP (hs-CRP), Standard CRP), By Detection Method (Immunoturbidimetry, Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Others), By Application (Cardiovascular Diseases, Infectious Diseases, Autoimmune Disorders, Others), By End User (Hospitals, Diagnostic Laboratories, Clinics, Home Care Settings), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Analysis and Forecast 2026–2035.
C-Reactive Protein Testing Market Size & Statistics
- The Market Size for C-Reactive Protein Testing Was Estimated to be worth USD 5.23 Billion in 2025.
- The Market is Going to Expand at a CAGR of 3.6% between 2026 and 2035.
- The Global C-Reactive Protein Testing Market Size is anticipated to reach USD 7.45 Billion by 2035.
- Asia Pacific is expected to grow the fastest during the forecast period in the C-Reactive Protein Testing Market.
- North America is expected to generate the highest demand during the forecast period in the C-Reactive Protein Testing market.
Regional growth and demand
Asia Pacific is expected to grow the fastest during the forecast period in the C-Reactive Protein Testing market. The region’s rapid expansion is driven by increasing prevalence of infectious and cardiovascular diseases, rising healthcare expenditure, and growing awareness of early disease diagnosis. Countries such as China, India, and Southeast Asian nations are investing in healthcare infrastructure, expanding diagnostic laboratories, and promoting point-of-care testing. Government initiatives supporting universal healthcare coverage, disease screening programs, and rural healthcare access are further accelerating CRP test adoption. Additionally, the growing presence of diagnostic companies and advancements in affordable testing technologies are strengthening market growth across the region.
In March 2026, Asia Pacific countries including China and India accelerated healthcare infrastructure investments and diagnostic capacity expansion, supporting increased adoption of CRP testing for early disease detection and chronic disease management.
North America is expected to generate the highest demand during the forecast period in the C-Reactive Protein Testing market. Demand is driven by well-established healthcare infrastructure, high adoption of advanced diagnostic technologies, and increasing focus on preventive healthcare. The United States and Canada are witnessing strong demand for high-sensitivity CRP tests for cardiovascular risk assessment and chronic disease management. Favorable reimbursement policies, continuous technological innovations, and rising investments in precision medicine and laboratory automation further support sustained market demand in the region.
In February 2025, the United States and Canada strengthened investments in clinical research and laboratory automation, enhancing CRP testing capabilities and supporting large-scale screening programs for inflammatory and chronic diseases.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the C-Reactive Protein Testing Market.
Ready to lead the C-Reactive Protein Testing Market?
Discover the regional trends and growth factors shaping the industry. We’re here to assist with expert, personalized data.
Call +1 303 800 4326 or Send us a message for a personalized consultation.
Top 10 Trends in the C-Reactive Protein Testing Market
• Increasing demand for early disease diagnosis and preventive healthcare
• Rising adoption of high-sensitivity CRP (hs-CRP) testing
• Expansion of point-of-care (POC) diagnostic solutions
• Growing prevalence of cardiovascular and inflammatory diseases
• Integration of AI and digital diagnostics in testing platforms
• Technological advancements in immunoassays and biosensors
• Increasing healthcare expenditure in emerging economies
• Rising demand for rapid and portable testing devices
• Strategic collaborations among diagnostic companies
• Expansion of laboratory automation and precision medicine
Top 5 Trends
1. Increasing Demand for Early Disease Diagnosis and Preventive Healthcare
The growing emphasis on early detection of diseases is significantly driving the adoption of CRP testing worldwide. CRP tests are widely used to identify inflammation and assess the risk of cardiovascular conditions at an early stage. Increasing awareness among patients and healthcare providers regarding preventive healthcare, along with routine health check-ups, is boosting market demand. Governments and healthcare organizations are also promoting early screening programs, which further support the widespread use of CRP testing as a reliable diagnostic tool in clinical practice.
2. Rising Adoption of High-Sensitivity CRP (hs-CRP) Testing
High-sensitivity CRP testing is gaining popularity due to its ability to detect low levels of inflammation associated with cardiovascular diseases. Healthcare professionals increasingly rely on hs-CRP tests for risk assessment and long-term disease monitoring. The rising burden of heart-related disorders and lifestyle diseases is further accelerating demand for these advanced diagnostic solutions. Additionally, clinical guidelines recommending hs-CRP testing for specific patient groups are supporting its integration into routine diagnostic protocols across hospitals and laboratories.
3. Expansion of Point-of-Care (POC) Diagnostic Solutions
The shift toward decentralized healthcare is driving the growth of point-of-care CRP testing devices. These solutions enable rapid diagnosis and immediate clinical decision-making, especially in emergency settings and remote locations. Portable CRP testing kits are becoming increasingly popular due to their ease of use and quick results. The demand for faster diagnostics, combined with improvements in device accuracy and affordability, is encouraging healthcare providers to adopt point-of-care testing, particularly in developing regions with limited access to centralized laboratories.
4. Growing Prevalence of Cardiovascular and Inflammatory Diseases
The increasing incidence of cardiovascular diseases, infections, and autoimmune disorders is a major factor fueling the CRP testing market. CRP levels serve as an important biomarker for inflammation, making these tests essential in diagnosing and monitoring various health conditions. Rising aging populations, sedentary lifestyles, and unhealthy dietary habits are contributing to the growing disease burden globally. This trend is significantly increasing the demand for reliable and efficient diagnostic tests such as CRP across healthcare systems.
5. Technological Advancements in Immunoassays and Biosensors
Continuous innovations in diagnostic technologies are transforming the CRP testing market. Advanced immunoassays, electrochemical biosensors, and microfluidic devices are improving test accuracy, sensitivity, and speed. Integration of digital platforms and AI-based analytics is further enhancing diagnostic efficiency and data interpretation. These technological advancements are enabling the development of compact, user-friendly, and highly precise testing solutions, making CRP testing more accessible across hospitals, clinics, and home care settings.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the C-Reactive Protein Testing market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the C-Reactive Protein Testing Market.
Top 25 Companies Leading the C-Reactive Protein Testing Market
- F. Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Becton, Dickinson and Company
- bioMerieux SA
- Ortho Clinical Diagnostics
- Randox Laboratories Ltd.
- Quidel Corporation
- Sekisui Diagnostics
- DiaSorin S.p.A.
- Mindray Medical International Limited
- Sysmex Corporation
- Trinity Biotech plc
- PerkinElmer Inc.
- Agappe Diagnostics Ltd.
- ERBA Diagnostics Mannheim GmbH
- Pointe Scientific Inc.
- Spinreact S.A.
- Tosoh Corporation
- Fujifilm Holdings Corporation
- HORIBA Ltd.
- Beckman Coulter, Inc.
- Nova Biomedical
1. F. Hoffmann-La Roche Ltd.
Headquarters: Basel, Switzerland
F. Hoffmann-La Roche Ltd. is a global leader in diagnostics and pharmaceuticals, offering advanced CRP testing solutions through its extensive immunodiagnostics portfolio. The company provides high-sensitivity CRP assays used in cardiovascular risk assessment and inflammation detection across hospitals and laboratories. Roche focuses on automation, digital integration, and precision diagnostics, enabling faster and more accurate results. Its cobas diagnostic platforms are widely adopted for high-throughput testing. With a strong global presence and continuous investment in research and development, Roche plays a key role in advancing CRP testing technologies and supporting modern healthcare systems worldwide.
2. Abbott Laboratories
Headquarters: Abbott Park, Illinois, United States
Abbott Laboratories is a major player in the global diagnostics market, offering a wide range of CRP testing solutions including point-of-care and laboratory-based assays. The company’s ARCHITECT and Alinity platforms support high-sensitivity CRP testing for cardiovascular and inflammatory disease management. Abbott focuses on innovation in rapid diagnostics, enabling healthcare providers to make timely clinical decisions. Its global distribution network and strong presence in emerging markets contribute to increased accessibility of CRP testing. The company continues to invest in advanced diagnostic technologies and digital health solutions to enhance testing efficiency and patient outcomes.
3. Siemens Healthineers AG
Headquarters: Erlangen, Germany
Siemens Healthineers AG provides comprehensive diagnostic solutions, including high-performance CRP testing assays integrated into its laboratory automation systems. The company’s Atellica and ADVIA platforms deliver accurate and efficient CRP measurements for clinical diagnostics. Siemens Healthineers emphasizes automation, AI integration, and digital healthcare transformation to improve diagnostic workflows. Its CRP testing solutions are widely used in hospitals and diagnostic laboratories for inflammation monitoring and disease management. With strong technological expertise and global reach, the company supports advanced diagnostics and contributes to the growth of the CRP testing market.
4. Thermo Fisher Scientific Inc.
Headquarters: Waltham, Massachusetts, United States
Thermo Fisher Scientific Inc. offers a broad portfolio of diagnostic reagents, immunoassays, and laboratory instruments used in CRP testing. The company provides high-quality assay kits and analytical platforms that support accurate detection of inflammatory biomarkers. Thermo Fisher focuses on innovation, research, and advanced laboratory solutions, enabling efficient and scalable testing processes. Its global presence and strong customer base across research institutions and healthcare facilities enhance the accessibility of CRP testing technologies. The company’s commitment to scientific advancement and precision diagnostics supports its leadership position in the global market.
5. Danaher Corporation
Headquarters: Washington, D.C., United States
Danaher Corporation, through its subsidiaries such as Beckman Coulter, provides advanced diagnostic systems and CRP testing solutions for clinical laboratories. The company focuses on high-sensitivity assays and automated platforms that improve testing accuracy and efficiency. Danaher emphasizes innovation in life sciences and diagnostics, supporting early disease detection and patient monitoring. Its technologies are widely used in hospitals and research laboratories worldwide. With continuous investment in research and strategic acquisitions, Danaher strengthens its position in the CRP testing market and contributes to advancements in diagnostic capabilities.
Are you ready to discover more about the C-Reactive Protein Testing market?
The report provides an in-depth analysis of the leading companies operating in the global C-Reactive Protein Testing market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the C-Reactive Protein Testing Market.
Company Profiles
- F. Hoffmann-La Roche Ltd.
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- Abbott Laboratories
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Becton, Dickinson and Company
- bioMerieux SA
- Ortho Clinical Diagnostics
- Randox Laboratories Ltd.
- Others.
Our Reports
https://www.sphericalinsights.com/reports/europe-anti-aging-supplements-market
https://www.sphericalinsights.com/reports/europe-ophthalmic-drugs-market
https://www.sphericalinsights.com/reports/europe-methanol-market
https://www.sphericalinsights.com/reports/germany-asphalt-pavers-market
https://www.sphericalinsights.com/reports/france-fertility-services-market
Conclusion
The C-Reactive Protein (CRP) testing market is expected to witness strong growth during the 2026–2035 forecast period, driven by the increasing prevalence of inflammatory, infectious, and cardiovascular diseases worldwide. CRP testing plays a vital role in early diagnosis and clinical decision-making by accurately detecting inflammation levels in the body. The rising focus on preventive healthcare and routine health screenings is significantly boosting demand, particularly for high-sensitivity CRP (hs-CRP) tests used in cardiovascular risk assessment. Technological advancements, including automated immunoassays, biosensors, and AI-integrated diagnostic systems, are enhancing testing accuracy, speed, and efficiency. Additionally, the growing adoption of point-of-care testing is improving accessibility in remote and decentralized healthcare settings. Government initiatives promoting early disease detection, along with increasing healthcare investments and infrastructure development, are further supporting market expansion. Overall, the market is set for substantial growth, driven by innovation, expanding applications, and rising global healthcare awareness.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?